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Creation and Initial 
Characterization of Isogenic 
Helicobacter pylori CagA EPIYA 
Variants Reveals Differential 
Activation of Host Cell Signaling 
Pathways
Dacie R. Bridge  1,5, Faith C. Blum1, Sungil Jang2, Jinmoon Kim2,3, Jeong-Heon Cha2,3,4 & 
 D. Scott Merrell1
The polymorphic CagA toxin is associated with Helicobacter pylori-induced disease. Previous data 
generated using non-isogenic strains and transfection models suggest that variation surrounding the 
C-terminal Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs as well as the number of EPIYA motifs influence disease 
outcome. To investigate potential CagA-mediated effects on host cell signaling, we constructed and 
characterized a large panel of isogenic H. pylori strains that differ primarily in the CagA EPIYA region. 
The number of EPIYA-C motifs or the presence of an EPIYA-D motif impacted early changes in host cell 
elongation; however, the degree of elongation was comparable across all strains at later time points. In 
contrast, the strain carrying the EPIYA-D motif induced more IL-8 secretion than any other EPIYA type, 
and a single EPIYA-C motif induced comparable IL-8 secretion as isolates carrying multiple EPIYA-C 
alleles. Similar levels of ERK1/2 activation were induced by all strains carrying a functional CagA allele. 
Together, our data suggest that polymorphism in the CagA C-terminus is responsible for differential 
alterations in some, but not all, host cell signaling pathways. Notably, our results differ from non-
isogenic strain studies, thus highlighting the importance of using isogenic strains to study the role of 
CagA toxin polymorphism in gastric cancer development.
Helicobacter pylori is causally associated with gastric and duodenal ulcers, gastric cancer, and MALT-lymphoma 
in approximately 20% of infected individuals1–4. Despite the identification of H. pylori’s role in gastric cancer 
development and classification of the bacterium as a class I carcinogen5, gastric carcinoma remains the third lead-
ing cause of cancer-related mortality6. H. pylori-associated disease development is a multifactorial process where, 
in addition to host, diet, and environmental factors7, H. pylori virulence factors contribute to disease progression; 
among these are the cag-pathogenicity island (cag-PAI)8, cytotoxin-associated gene A (CagA), vacuolating toxin 
A (VacA), and numerous outer membrane proteins9. The cag-PAI is carried by the majority of H. pylori strains 
and encodes a type IV secretion system (T4SS) that is responsible for CagA translocation directly into host cells8. 
H. pylori strains encoding the cag-PAI and CagA are more virulent8, 9.
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CagA was defined as an oncoprotein due to its ability to induce gastric polyps and adenocarcinoma when 
transgenically expressed in mice10. Extensive in vitro studies have shown that following translocation into host 
cells, CagA binds to the inner leaflet of the host cell plasma membrane and is phosphorylated by c-Src and 
c-Abl at tyrosine residues located in the C-terminal Glu-Pro-Ile-Tyr-Ala (EPIYA) sequence of the protein11–16. 
Phosphorylated CagA then induces aberrant host cell signaling through formation of a complex with more than 
20 host cell proteins17, chief among these is SHP-218, 19. Subsequent host cell signaling pathway stimulation results 
in host cell elongation termed the “hummingbird phenotype”20, which is characterized by loss of host cell polarity 
and tight junction formation, cytoskeletal rearrangements, and increased host cell motility21–24. CagA also acti-
vates proteins that increase host cell proliferation and aberrant host cell survival25, 26, and induces host inflam-
matory responses primarily through modulation of nuclear factor-κB (NF-κB)27, 28. Together the ability of H. 
pylori29–31 and CagA32, 33 to deregulate these host cell processes contributes to epithelial-to-mesenchymal transi-
tion (EMT)34, which in turn may contribute to gastric carcinogenesis9.
A significant factor in host cell pathway modulation is allelic variation in the CagA C-terminal EPIYA motifs35; 
the number of EPIYA repeats and the amino acid sequences that surround the repeats vary across H. pylori 
strains36. As such, strains originating from the United States, Europe, and Australia contain EPIYA-A, -B, and 
-C alleles, while strains originating from Japan, South Korea, or China contain EPIYA-A, -B, and -D alleles37, 38. 
The timing and degree of CagA phosphorylation appears to be dependent on the EPIYA motif that is present. In 
this regard, EPIYA-C and -D motifs are preferentially phosphorylated by c-Src early in infection, whereas c-Abl 
can phosphorylate all four motifs at later time points39. However, despite the importance of CagA in disease 
progression, it remains unclear how variation in the EPIYA region of the toxin ultimately affects various host 
cell signaling pathways. While numerous studies have sought to define the importance of CagA polymorphism 
in host cell changes24, 35, 40–42, most of that work was conducted using non-isogenic strains or transfection assays. 
Therefore, those results may not recapitulate what would occur during a natural infection or may be influenced 
by H. pylori’s high rate of genetic variability9. To date a single collection of isogenic strains (CagA EPIYA-AB, 
-ABC, and -ABCCC alleles) has been constructed to study the role of the CagA EPIYA motif variation in host cell 
signaling33, 43, 44. Of note, the EPIYA-ABD form of the toxin is significantly associated with gastric cancer develop-
ment41; it is believed to activate signaling pathways more efficiently than a single EPIYA-C allele due to a stronger 
binding interaction with SHP-235. Therefore, the absence of the CagA EPIYA-ABD allele in the aforementioned 
isogenic strain panel may prevent identification of pathways altered solely by the EPIYA-D motif. Furthermore, 
strains containing additional EPIYA-C combinations are found in nature45.
To expand our understanding of the significance of CagA polymorphism, we developed a set of H. pylori 
isogenic strains that differ primarily in the CagA EPIYA region. Though not exhaustive, our collection was 
designed to encompass some of the most commonly found CagA variants seen in H. pylori clinical isolates. 
Herein, we describe the construction and preliminary characterization of a H. pylori G27 isogenic strain collec-
tion that contains EPIYA-AB, -ABC, -ABCC, -ABCCC, -ABCCCC, and -ABD alleles of the CagA toxin. As addi-
tional comparators, we constructed isogenic strains that were deficient in CagA (ΔcagA), contained a deletion of 
the CagA EPIYA region (ΔEPIYA), were lacking the cag-PAI (ΔPAI), contained an insertion mutation leading 
to expression of just a portion of the CagA N-terminus (cagA::cat), or were restored to the G27 wild type (WT) 
EPIYA type (ABCC Restorant). Characterization of the isogenic strain panel suggests CagA EPIYA-dependent 
differential regulation of some host cell signaling pathways. Thus, our study highlights the importance of using 
isogenic strains to characterize differences in CagA EPIYA-dependent induction of host cell signaling.
Results
Construction and basic characterization of isogenic H. pylori strains that differ primarily in the 
CagA EPIYA region. Previous studies indicate that variation in the CagA EPIYA region contributes to differ-
ences in disease progression23, 34, 39–41. However, those studies were largely completed utilizing transfection models 
or non-isogenic strains. Thus, the previous results may not recapitulate what occurs during a natural infection or 
solely depend on CagA, respectively. To this end, we created H. pylori isogenic strains in G27 that differ primarily 
in the CagA EPIYA region (Supplementary Figure S1) and encompass the following variants: EPIYA-ABT, -ABTC, 
-ABTCC, -ABTCCC, -ABTCCCC and -ABTD (Fig. 1a). The following control strains were created for comparison 
purposes: ΔcagA, cagA::cat, ΔEPIYA, and a G27 strain restored to the WT ABCC genotype (Fig. 1a). Thus, a total 
of 10 isogenic strains were created and characterized alongside WT G27.
Western blot analysis revealed that the size of the CagA protein expressed from each of the isogenic strains 
reflected the expected size of the protein based on the number of EPIYA motifs (Fig. 1b). Moreover, each of the 
control strains showed the expected loss or change in CagA size compared to WT G27 (Fig. 1b). Characterization 
of the in vitro growth characteristics of the isogenic strains revealed growth kinetics that virtually mirrored the 
parental G27 strain (Supplementary Fig. S2). Moreover, EPIYA variation appeared to play no significant role 
in bacterial adherence to or internalization into AGS cells (Supplementary Fig. S2). To ensure that each of the 
strains retained the ability to translocate CagA into host cells, whole cell lysates of infected AGS cells were ana-
lyzed by Western blot using anti-CagA and anti-phosphotyrosine antibodies. While equivalent levels of CagA 
were expressed by each strain, varying levels of phosphorylated CagA were detected for each isogenic strain 
(Fig. 1c). No phosphorylated band was detected for the uninfected cells or the cagA::cat, ΔEPIYA, or ΔcagA 
controls (Fig. 1c and Supplementary Fig. S2). Additionally, CagA translocation and phosphorylation by the 
ABCC Restorant was comparable to WT G27 (Supplementary Fig. S2). Taken together, these data suggest that the 
isogenic strain collection may be a useful tool to study downstream effects of translocation and phosphorylation 
of the various CagA variants.
Effect of EPIYA variation on host cell elongation. Following translocation, phosphorylated 
CagA induces host cell signaling changes that result in a dramatic cell elongation termed the “hummingbird 
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Figure 1. Construction and characterization of the G27 CagA isogenic strains. (a) H. pylori G27 (CagA 
EPIYA-ABCC) was used to construct isogenic strains that differ primarily in the form of CagA expressed. The 
C-terminal EPIYA region of WT G27 was replaced with the counter-selectable kan-sacB cassette (gray box) to 
create the ΔEPIYA strain. The EPIYA-ABT, -ABTC, -ABTCC, -ABTCCC, -ABTCCCC motifs were PCR amplified 
from clinical isolate K154, while the EPIYA-ABTD was amplified from the clinical isolate K3. Of note, as the 
EPIYA-B motif of K154 contains a natural alanine to threonine mutation (denoted as BT), the EPIYA-B motif 
alanine of EPIYA-ABD from K3 was mutated to EPIYT. The ΔEPIYA strain was naturally transformed with 
vectors carrying the various EPIYA constructs and the kan-sacB cassette was replaced via double homologous 
recombination. As controls, the entire cagA coding sequence was replaced with a kan-sacB cassette (ΔcagA), 
a truncated CagA protein was constructed with the addition of a cat cassette (light blue box; cagA::cat), and 
as a control for genetic manipulation, the ΔEPIYA strain was restored to its WT genotype (ABCC Restorant). 
Blue-G27 genomic DNA sequence; Green-G27 cagA sequence; White-7.13 flanking sequence; Orange-EPIYA-A 
motif; Red-EPIYA B motif; Purple-EPIYA-C motifs; Yellow-EPIYA-D motif; (b). The isogenic strains were 
analyzed for proper deletion, truncation, or expression of CagA by Western blot. For the image on the right, the 
Western blot image was cropped to show only the region corresponding to CagA (c). AGS cells were infected 
with each isogenic strain at an MOI of 100 for 8 hrs and whole cell lysates were analyzed by Western blot using 
anti-CagA and anti-phosphotyrosine antibodies to detect total (CagA) and phosphorylated CagA (pTyr). The 
Western blot images were cropped to show only the region corresponding to CagA (top) and phosphorylated 
CagA (bottom). Together, the panel of isogenic strains was able to secrete CagA that could be translocated and 
phosphorylated in AGS cells.
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phenotype”20, 27. Previous studies suggest that cellular elongation may be effected by variation in the EPIYA region 
of CagA46. To investigate this possibility, AGS cells were infected with the isogenic strains and host cell elonga-
tion was monitored temporally by measuring the maximum length and breadth of cells (illustrated in Fig. 2a). 
Uninfected cells were maintained as controls and remained largely unchanged throughout the experiment 
with a mean length/breadth ratio of 1.97 to 2.26 (Fig. 2b). Similarly, infection with the cagA::cat strain resulted 
in no significant changes in cell shape (mean length/breadth ratio of 2.43 to 2.66; Fig. 2b and Supplementary 
Table S1). Conversely, AGS cells infected with strains carrying a functional CagA protein produced elongated 
cellular projections (Fig. 2a) that resulted in significant time-dependent changes in the length/breadth ratio as 
compared to uninfected cells or to cells infected with the cagA::cat strain (Fig. 2b; Supplementary Table S1). 
Significant differences in host cell elongation across the strains were most pronounced at 3 hrs post-infection 
but the degree of elongation appeared more similar at later time points (Supplementary Table S1). In regard 
to the EPIYA variants, AGS cell elongation was significantly increased at 3 and 6 hrs for all strains expressing 
CagA that contained at least one EPIYA-C motif or the EPIYA-D motif as compared to cells infected with the 
EPIYA-ABT strain (Fig. 2b, Supplementary Table S1). Furthermore, at 3 hrs post-infection, strains containing an 
EPIYA-ABTCCC, -ABTCCCC, or -ABTD motif induced significant changes as compared to EPIYA-ABTC infected 
cells. In this regard, the EPIYA-ABTCCCC strain induced more elongation than strains with two EPIYA-C motifs 
(EPIYA-ABTCC and WT G27; Fig. 2, Supplementary Table S1). By 6 hrs the differences between the strains con-
taining at least one EPIYA-C motif or the EPIYA-D motif were no longer apparent. Finally, AGS cells that were 
infected with the ΔcagA, ΔEPIYA, cagA::cat, WT G27, or the ABCC Restorant strains showed the expected phe-
notypes (see Supplementary Fig. S3 and Supplementary Table S2).
As most prior studies that have evaluated EPIYA-dependent changes in AGS cell elongation have focused on 
the percentage of cells that became elongated upon infection, we also evaluated our data in this manner. For this 
analysis, we grouped the relative length/breadth ratios based on the length/breadth ratios that were observed for 
the uninfected control cells at the 3 hr time point. At this point ~95% of uninfected control cells had a length/
breadth ratio of less than 4 (Fig. 2c), therefore, all cells with a ratio of less than 4 were grouped together. The 
remaining cells were grouped such that the degree of elongation could be differentiated as moderate (length/
breadth of 4 < 8) or extreme (length/breadth ≥ 8). Based on these criteria, at the 3 hr time point the percentage 
of moderately elongated cells correlated with an increase in the number of EPIYA-C motifs or the presence of 
an EPIYA-D motif. However at 6 and 9 hrs post-infection, the percentage of elongated cells plateaued at 60–65% 
(Fig. 2c). Furthermore, at these later time points, the percentage of cells that had projections between 4 and 8 
or greater than 8 appeared similar across the strains with at least one EPIYA-C or an EPIYA-D motif. En masse, 
these results suggest that while variation in the EPIYA-C and EPIYA-D motif affects the timing of induction of 
host cell elongation, the presence of multiple EPIYA-C motifs or an EPIYA-D motif does not ultimately result in 
significantly greater levels of host cell elongation in the AGS model.
Effect of EPIYA variation on IL-8 secretion. H. pylori infection results in a chronic inflammatory 
immune response that includes secretion of the cytokine IL-847, 48. While induction of IL-8 is dependent on the 
presence of the T4SS8, 49–51, studies indicate that CagA also contributes to IL-8 secretion at later time points40, 52–54. 
Thus, to determine if CagA EPIYA variation influenced IL-8 secretion in infected AGS cells, IL-8 was moni-
tored at 12, 24, and 36 hrs post-infection (Fig. 3). IL-8 secretion was significantly increased at all time points in 
cells infected with H. pylori as compared to uninfected controls (P = 0.0001 for all comparisons). Furthermore, 
CagA-dependent increases in IL-8 were evident at 24 and 36 hrs post-infection where IL-8 production was sig-
nificantly higher in isogenic strains expressing an intact EPIYA motif as compared to the cagA::cat infected cells 
(P = 0.0001). Strains containing the EPIYA-ABT, -ABTC, -ABTCC, -ABTCCC, and -ABTCCCC motifs induced 
virtually identical levels of IL-8 across all time points with no significant differences across these strains and 
were comparable to WT G27. In contrast, when cells were infected with the EPIYA-ABTD strain, IL-8 secre-
tion was significantly higher than with other strains at 24 hrs [EPIYA-ABT (P = 0.0026), -ABTCCC (P = 0.0334), 
and WT G27 (P = 0.0008)], and at 36 hrs [EPIYA-ABT (P = 0.0001), EPIYA-ABTC (P = 0.0088), EPIYA-ABTCCC 
(P = 0.0403), EPIYA-ABTCCCC (P = 0.0179), and WT G27 (P = 0.0129)]. As in the previous assays, infection 
with the ABCC Restorant, cagA::cat, ΔEPIYA, and ΔcagA strains yielded the expected results (see Supplementary 
Fig. S4). Together, these results indicate that the CagA EPIYA region is required for maximal IL-8 secretion and 
suggest that the presence of one or several EPIYA-C motifs does not result in increased IL-8 secretion beyond 
what is seen in the ABT strain. Conversely, and in contrast to the cell elongation data (Fig. 2), the presence of an 
EPIYA-D motif results in maximal IL-8 secretion that increases in a temporal fashion.
Effect of EPIYA Variation on CagA Translocation and Phosphorylation, and on Extracellular 
Regulated Kinase 1/2 (ERK1/2) Activation. Previous studies have shown that CagA that contains mul-
tiple EPIYA-C motifs undergoes more tyrosine phosphorylation than variants with a single EPIYA-C motif. 
Additionally, the presence of multiple EPIYA-C repeats increases binding activity to SHP-235, 46. However, the 
EPIYA-D motif contains a perfect SHP-2 binding motif and can activate SHP-2 more effectively than an EPIYA-C 
motif27, 55, 56. Therefore, to begin to study how CagA C-terminal polymorphism alters a host cell signaling pathway 
associated with gastric cancer development, we infected AGS cells with the isogenic strains and utilized Western 
blot to temporally monitor total CagA, CagA delivery and phosphorylation, and ERK1/2 activation in a temporal 
manner (see Supplementary Figure S5 for a representative Western blot compilation). As the T4SS is known to 
activate host cell signaling pathways57, we also constructed a G27 ΔPAI strain as an additional comparator. When 
we quantitated CagA delivery over time, detectable CagA phosphorylation was observed for most strains by 1 hr, 
increased until the 4–5 hr time point, and then plateaued (Fig. 4a). Higher levels of phosphorylation tended to be 
observed with the EPIYA-ABTCCCC motif followed by the EPIYA-ABTCC, -ABTC, and WT G27 strains (Fig. 4a). 
As strains missing CagA (ΔPAI and ΔcagA) or containing a truncated CagA (cagA::cat and ΔEPIYA) do not 
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Figure 2. CagA EPIYA-C and -D motifs affect the timing but not the ultimate overall level of AGS cell 
elongation. AGS cells were infected with the isogenic strains at an MOI of 10 for 3, 6, or 9 hrs. The cells were 
fixed and imaged by DIC microscopy. (a) The relative length/breadth ratio was determined based on the 
maximum length of the cell divided by the maximum width of the cell as illustrated for uninfected (left panel) 
or infected cells (right panel). (b). The relative length/breadth ratios for each time point were graphed using a 
Tukey’s box and whisker plot to show the distribution of ratios across time. Ratios that were greater than the 75th 
percentile +the 1.5 IQR are shown as individual data points. Significance was determined by an Ordinary one-
way ANOVA (Supplementary Table S1). Overall, for all time points, AGS cell elongation for all infected strains 
was significantly increased compared to uninfected or cagA::cat infected cells (P < 0.0001). At the 3 hr and 6 hr 
time points, cells infected with strains expressing any number of EPIYA-C motifs or an EPIYA-D motif were 
significantly increased compared to cells infected with an EPIYA-ABT motif, whereas at the 9 hr time point, 
only the EPIYA-ABTC and WT G27 were significant as compared to the EPIYA-ABT motif (see Supplementary 
Table S1 for statistical values). (c) The relative length/breadth ratios were grouped (0 < 4, 4 < 8, ≥ 8) and the 
percentage of elongated cells was determined. At 3 hrs post-infection, there was an increase in the percentage 
of cells that elongated when infected with strains expressing increasing numbers of EPIYA-C motifs or the 
EPIYA-D motif. However, the percentage of cells that elongated with any EPIYA-C or -D motif plateaued at 6 
and 9 hrs post-infection. The data represent three independent experiments.
www.nature.com/scientificreports/
6SCiEntiFiC REPoRTS | 7: 11057  | DOI:10.1038/s41598-017-11382-y
contain phosphorylatable residues, the phosphorylation signal clustered with that of the uninfected AGS cells, 
which was below that of WT G27 and the ABCC Restorant (Fig. 4b). Total CagA increased with time for strains 
that contained an intact EPIYA motif; polymorphism in the CagA EPIYA motif had no substantial effect on the 
amount of detectable total CagA between these strains (Fig. 4c). As expected, no CagA signal was detected above 
background levels for the uninfected controls, the ΔPAI, or the ΔcagA infected cells (Fig. 4c). Strains containing 
a truncated CagA (cagA::cat or ΔEPIYA) showed a temporal increase in the truncated form of CagA, however, 
this increase lagged behind and remained decreased compared to strains with an intact CagA EPIYA region 
(Fig. 4c). These differences in total CagA between the full length and truncated proteins should be independent 
of antibody recognition; the polyclonal CagA antibody that was used was raised against amino acids 1–300 of the 
protein, which are identical in these isogenic strains.
We next monitored ERK1/2 activation by measuring total ERK1/2 and ERK1/2 phosphorylation (pERK1/2). 
We found that total ERK1/2 remained constant throughout the experiment (Fig. 4d) and that there were no 
appreciable differences in ERK1/2 activation across strains with an intact EPIYA motif (Fig. 4e). However, we 
did observe two peaks in ERK1/2 activation in these strains. The first peak occurred 1 hr post-infection and then 
steadily declined until a second activation peak occurred at 4 hrs post-infection. The later peak remained elevated 
for all strains with an intact EPIYA region (Fig. 4e and f). The initial peak in ERK1/2 activation can be attrib-
uted to the presence of the cag-PAI, as the G27 ΔPAI strain did not induce ERK1/2 activation at this time point 
(Fig. 4f). Together, the data indicate that while polymorphisms in the CagA EPIYA motifs do not appear to affect 
CagA expression, there is a trend towards increased phosphorylation with strains containing multiple EPIYA-C 
motifs. Secondly, sustained increases in ERK1/2 activation occurred beginning at 4 hrs post-infection, regardless 
of EPIYA type. Thus, in this model system CagA-dependent activation of ERK1/2 appears to not be dramatically 
affected by CagA EPIYA variation.
Discussion
Based on polymorphism in its C-terminal EPIYA motifs, the oncoprotein CagA is responsible for causing 
alterations in host cell signaling pathways that impact the development of gastric cancer17. However, previous 
studies have utilized non-isogenic strains or transfection models to study the role of EPIYA polymorphism in 
infection and gastric cancer development. Recently, a limited panel of isogenic H. pylori CagA EPIYA variants 
was constructed and characterized in the P12 strain background and included EPIYA-AB, -ABC, and -ABCCC 
motifs, but did not include the more virulent -ABD motif33, 43, 44. As such, to begin to determine how EPIYA 
polymorphism influences gastric cancer development, we created a larger panel of strains in the H. pylori G27 
strain background; the panel was designed to encompass the most commonly found EPIYA motifs in clinical set-
tings. Additionally, we created control strains that were deficient for CagA or encoded truncated forms of CagA. 
Characterization of the EPIYA variants showed that CagA was expressed and was translocated into and phospho-
rylated in AGS cells. Pathway analysis revealed that increasing numbers of EPIYA-C repeats or the presence of the 
EPIYA-D motif significantly increased host cell elongation, though these differences were only evident in early 
stages of infection. Furthermore, IL-8 secretion occurred in both a CagA EPIYA-dependent and independent 
fashion where maximal IL-8 secretion depended on the presence of an EPIYA-ABD motif. We found that levels 
of CagA phosphorylation trended higher in strains carrying an EPIYA-C motif. Lastly, we found that activation 
of ERK1/2 occurred in a cag-PAI-dependent manner. CagA-independent activation occurred early in infection, 
while CagA-dependent activation occurred mid-infection and remained sustained regardless of EPIYA type.
Figure 3. Presence of an EPIYA-D motif induces the greatest IL-8 secretion. AGS cells were infected with 
the isogenic strains at an MOI of 10. A sample of the co-culture supernatant was taken at 12, 24, and 36 hrs 
post-infection and analyzed by ELISA for total IL-8. At all time points, there was a significant increase in IL-8 
secretion in cells infected with H. pylori (P = 0.0001 for all comparisons, two-way ANOVA). At 24 and 36 hrs, 
there was a significant increase in IL-8 secretion from cells infected with H. pylori expressing CagA with an 
intact EPIYA motif as compared to the truncated CagA protein (P = 0.0001, two-way ANOVA). There was no 
difference in secretion from cells infected with increasing EPIYA-C motifs. *Indicates significance compared to 
EPIYA-ABTD at 24 hrs; ^Indicates significance compared to EPIYA-ABTD at 36 hrs. ELISA data are presented as 
the geometric mean +95% confidence interval and represent three independent experiments.
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The clinical isolate that served as the template for the isogenic strain construction contains a natural alanine to 
threonine amino acid change in the EPIYA-B motif. At the time of our strain construction, this EPIYA variation 
was not identified as biologically significant, however a recent publication showed that the EPIYT-B sequence 
has a higher affinity for the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway and that a strain 
containing this allele is attenuated for host cell elongation and IL-8 secretion as compared to an isogenic EPIYA-B 
strain58. Zhang et al. proposed that the EPIYT-B sequence may allow for increased CagA tyrosine phosphoryl-
ation to occur, which in turn, regulates phosphorylation-dependent PI3K/Akt activation to regulate host cell 
cytoskeletal rearrangements and cytokine secretion58. It was also suggested that EPIYT-B motif-induced host 
Figure 4. CagA EPIYA polymorphism effects on CagA translocation, phosphorylation, and activation of 
ERK1/2. AGS cells were infected with the isogenic strains at an MOI of 100 and cells were harvested in a 
temporal fashion. Lysates were then analyzed for (a and b) phosphorylated CagA (pTyr), (c) total CagA (CagA), 
(d) total ERK1/2 (ERK1/2) and (e and f) phosphorylated ERK1/2 (pERK1/2). Data were normalized to GAPDH 
and the value at time zero for each strain for each protein of interest was designated as “1” and variation from 
that value were then plotted temporally. The data are displayed as the geometric mean of four biologically 
independent experiments.
www.nature.com/scientificreports/
8SCiEntiFiC REPoRTS | 7: 11057  | DOI:10.1038/s41598-017-11382-y
cell elongation might relate to a competition in binding between PI3K and C-Src kinase (CSK) or SHP-2 at this 
domain58. We note that while utilization of isogenic strains containing the EPIYT-B motif could impact our 
results, we did not observe a significant decrease in host cell elongation or IL-8 secretion that appeared linked to 
the EPIYT polymorphism; data obtained from WT G27 (EPIYA-ABCC), the ABCC Restorant and the isogenic 
EPIYA-ABTCC strain were comparable. Therefore, in the context of our studies, and within the G27 strain back-
ground, perhaps any potential increased PI3K/Akt/EPIYT-B binding is over-shadowed by other activated signal-
ing cascades. Further studies will need to be conducted to evaluate this phenomenon. However, our data strongly 
suggest that our isogenic strain collection can serve as a model system to study CagA EPIYA-mediated changes 
in host cell signaling pathways.
During H. pylori infection, CagA is known to induce the characteristic “hummingbird phenotype” in host 
epithelial cells20, 27. Several studies have proposed that increased levels of CagA phosphorylation correlated with 
increased host cell elongation14, 35, 40, 59. In this regard, transfected CagA constructs with increasing numbers of 
EPIYA motifs induce greater host cell elongation35. Similarly, comparison of non-isogenic strains suggests that 
levels of host cell elongation are reduced when the number of CagA motifs is reduced14. Furthermore, meas-
urement of host cell projections showed that the number of elongated cells correlated with the amount of CagA 
tyrosine phosphorylation59 and that the number and overall length of elongated cells increased with increasing 
numbers of EPIYA motifs40. Lastly, the recent P12 isogenic strain study found that at 24 hrs post-infection, cell 
scattering was proportional to the number of expressed EPIYA-C motifs44. Utilizing our isogenic strain collection 
and temporal quantitation of host cell elongation, our data suggest that EPIYA-dependent increases in host cell 
elongation occurs early in infection and that a single EPIYA-C motif is sufficient to initiate maximal host cell 
elongation at later points. The presence of the CagA EPIYA-D allele does not induce more host cell elongation 
than the presence of an EPIYA-C allele as the timing and overall host cell elongation patterns were similar among 
these strains and plateaued identically at the later time points. Thus, utilization of our isogenic strain collection as 
a means to remove extraneous H. pylori variables suggests that within the AGS model system, host cell elongation 
is influenced by polymorphisms in the CagA EPIYA region only early in infection; however, we do note that it 
may be possible that lack of a difference in host cell elongation at later time points may be due to saturation of the 
elongation phenotype in the AGS model. Thus, future analyses in other cell types may be beneficial.
We note that direct comparison of our results to prior studies is difficult due to differences in methodology; 
despite this, we note the benefit of considering our work within the context of those prior studies. For exam-
ple, previous data generated using transfected CagA constructs suggest that CagA variants that interact with 
CSK stronger than with SHP-2 attenuate host cell elongation56. That finding suggests that strains that carry the 
EPIYT-B motifs, which may interact less strongly with the CSK pathway than the isogenic EPIYA-B motif58, 
should result in differences in cell elongation in our assay. However, as previously discussed, we did not observe 
such a difference. While the reason for this discrepancy is unclear, future work to investigate this will include 
more extensive pathway characterization. While the significance of the timing of CagA-induced host cell elon-
gation remains unclear, CagA phosphorylation and EPIYA region variations are suggested to result in activation 
of host cell signaling pathways that contribute to EMT, a hallmark of tumorigenesis that involves the loss of epi-
thelial cell polarization and cell-to-cell contacts and the acquisition of increased motility34. CagA’s role in EMT is 
attributed to inhibition of focal adhesion retraction in the trailing edge of migrating cells60, activation of SHP-2, 
inhibition of PAR1 homolog b (Par1b)22, 23, and alteration of EMT markers32, 33, 61, 62. In H. pylori strains with mul-
tiple CagA EPIYA-C motifs, the interaction between CagA and SHP-2 is enhanced56, 63, CagA binding to Par1b 
increases exponentially64, and expression and phosphorylation of the EPIYA-C motifs transcriptionally regulates 
EMT markers and stem cells in a phosphorylation-dependent manner33. Thus, it will be interesting to use our 
constructed isogenic strain panel for future live-cell imaging studies that will investigate EMT specific pathways; 
additional time points post-infection can be used to more accurately assess host cell elongation kinetics.
Upon infection, H. pylori induces host cell inflammation that includes the secretion of cytokines, such as 
IL-847, 48. IL-8 secretion is induced in response to the T4SS early in infection8, 49–51, while a role for CagA has 
been suggested at later time points40, 52–54. However, further work aimed at investigating the role of CagA EPIYA 
polymorphism in IL-8 secretion has yielded inconsistent results. First, several studies using non-isogenic clin-
ical strains found that EPIYA variation has no significant association with the amount of IL-8 secreted by AGS 
cells following a short infection (3–6 hrs)40, 54. Subsequent studies indicate a role for CagA-dependent, but phos-
phorylation independent, effects of IL-8 secretion at later time points post-infection (greater than 36 hrs)53, 65. 
Conversely, a study that assessed time points at 6 and 36 hrs post-infection found that increasing numbers of 
EPIYA-C motifs significantly increased IL-8 secretion and that the increase was even more dramatic in the pres-
ence of an EPIYA-ABD motif38. Conversely, results from the H. pylori P12 isogenic strain collection revealed no 
difference in IL-8 secretion among strains containing varying numbers of EPIYA-C motifs44. Our results utiliz-
ing the expanded G27 isogenic strain panel further support the P12 isogenic strain panel findings. We found 
infection-dependent IL-8 secretion early in infection (12 hrs post-infection) and CagA-dependent IL-8 induc-
tion at later time points (>24 hrs post-infection). Regardless of the number of EPIYA-C motifs, the presence of 
a single EPIYA-C motif was enough to induce maximal IL-8 secretion. However, the amount of IL-8 induced by 
the EPIYA-ABD strain was the highest. Interestingly, this finding differs from our cell elongation results, where 
maximal elongation occurred in the presence of either an EPIYA-C or -D motif. En masse, our data support the 
hypothesis that CagA influences IL-8 secretion in an EPIYA-dependent manner where the EPIYA-D motif is crit-
ical for maximal induction of secretion. Furthermore, increasing EPIYA-C motifs appear to not greatly influence 
IL-8 secretion levels in a model of natural infection (refs 43 and 44, and this study).
Upon initial investigation, we observed differences in overall CagA translocation into and phosphorylation 
in AGS cells. Given that CagA phosphorylation is known to influence changes in host cell signaling that affect 
EMT, cytokine production, and gastric carcinogenesis, we investigated temporal translocation and phospho-
rylation of CagA as well as associated ERK1/2 activation. Previous studies have shown that CagA translocation 
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and phosphorylation varies by host cell type; in AGS cells, translocation was observed within 1 hr of infection66. 
A CagA transfection study indicated that overall levels of phosphorylation are proportional to the number of 
EPIYA-C motifs56. Our results are consistent with these observations as phosphorylated CagA was detected for 
most of the isogenic strains around 1 hr post-infection, temporally increased thereafter, and showed the highest 
levels in the strain containing the most EPIYA-C motifs. ERK1/2 activation following infection with the various 
isogenic strains followed a biphasic pattern. The first peak in ERK1/2 activation occurred immediately following 
infection and was T4SS-dependent, while the second peak occurred several hours post-infection, was sustained 
throughout the assay, and was CagA-dependent. These results are fairly consistent with previous studies that indi-
cate that CagA has a role in ERK1/2 activation but that this role is most evident later in infection. For example, 
rapid ERK1/2 activation (within 15 min of infection) was shown to be similar between H. pylori strains regard-
less of CagA status, but CagA positive strains induced sustained levels of ERK1/2 activation67. Those authors 
proposed that CagA tyrosine phosphorylation was required for optimal late ERK1/2 activation and that early 
CagA-independent activation was mediated by Raf and MEK but not Ras, whereas later activation included all 
three pathways67. Transfected CagA has also been shown to result in prolonged ERK1/2 activation that is medi-
ated by SHP-227. In comparison to our own data, the P12 isogenic strain collection study also found early and late 
ERK1/2 activation. However, in contrast to our results, early activation appeared to be influenced by the presence 
of EPIYA-C motifs; the P12 AB strain induced lower levels of early activation as compared to the P12 ABCCC 
strain. Further, Papadakos et al. found that late ERK activation appeared to be highest in the P12 strains lacking 
EPIYA-C motifs: AB and ΔcagA43. Though not completely clear, the reason for the differences between these 
isogenic strain studies may be based on strain differences (P12 vs G27), experimental setup (RPMI + 10%FBS 
vs F-12K + 2% FBS), etc. The data presented herein seem to suggest that H. pylori-mediated ERK1/2 activation 
follows a biphasic pattern. Early activation requires the T4SS but not CagA, whereas sustained ERK1/2 activation 
specifically requires CagA. As previously suggested, and as supported by the overall low levels of CagA phospho-
rylation we observed in the present study, the CagA toxin appears very potent since it appears to be able to modify 
host cell signaling pathways with minimal levels of CagA translocation and phosphorylation63, 68.
In conclusion, our study supports the paradigm that CagA polymorphisms in the C-terminus affects host 
cell signaling pathways that vary based on the number of and type of CagA EPIYA-motifs that are expressed. 
Furthermore, we show that our isogenic strain collection serves as a good model to study differences in host cell 
signaling pathways of interest. One caveat that must be considered when interpreting our results is that there 
are additional natural amino acid differences that occur in the C-terminus of CagA that lie outside of the EPIYA 
motifs (Supplementary Figure S1). Therefore, future studies will be required to determine whether these amino 
acid differences contribute to CagA-mediated effects as well as to dissect how the EPIYA polymorphisms influ-
ence specific pathways that lead to gastric carcinogenesis.
Methods
Bacterial strains, plasmids, and eukaryotic cell lines. Strains and plasmids are listed in Table 1. H. 
pylori was cultured as previously described69. Briefly, H. pylori were grown on blood plates for 24–48 hrs prior 
to transfer to liquid starter cultures. H. pylori liquid starter cultures were grown at 37 °C for 18–24 hrs shaking 
at 110 rpm in Brucella broth (BB) supplemented with 10% fetal bovine serum (FBS) and 10 µg/mL vancomycin 
(Vanc). For experimentation, liquid H. pylori starter cultures were diluted to 0.05 OD unit/mL (ODU) at 600 nm 
and cultured for 16–18 hrs. Where denoted in Table 1, cultures and plates were supplemented with 8 µg/mL chlo-
ramphenicol (CM), 25 µg/mL kanamycin (Kan), or 5% sucrose (Suc). All H. pylori cultures were grown under 
microaerobic conditions (5% O2, 10% CO2, and 85% N2) established using an Anoxomat gas evacuation and 
replacement system (Advanced Instruments, Inc., Norwood, MA) in gas evacuation jars. Escherichia coli strains 
were maintained as frozen stocks in Luria Broth (LB) containing 40% glycerol at −80 °C. Plasmids were isolated 
and purified using Qiagen reagents (Qiagen; Valencia, CA) from cultures grown in the presence of 100 μg/mL 
ampicillin (Amp), and 25 μg/mL Kan or 8 μg/mL CM.
The AGS (CRL-1739) gastric adenocarcinoma cell line was obtained from the American Type Culture 
Collection (ATCC; Manassas, Virginia). AGS cells were cultured in Ham’s F-12K Nutrient Mixture, Kaighn’s 
Mod. with L-glutamine (F-12K; Corning Cellgro, Mediatech, Inc., Manassas, VA) supplemented with 10% FBS 
and 10 µg/mL Vanc at 37 °C, 5% CO2 as per ATCC recommendations. For all experiments, AGS cells were seeded 
in 6-well tissue culture plates.
H. pylori Isogenic Strain Construction. All H. pylori strains were constructed in the G27 strain back-
ground11, 70 using splicing by overlap extension (SOE) PCR with the primers listed in Supplementary Table S3. 
Detailed methods for the isogenic strain construction can be found in the Supplementary Methods online. Briefly, 
the C-terminal EPIYA region of WT G27 was replaced with a counter-selectable kanamycin resistance determi-
nant aphA3/sacB (kan-sacB)71, 72 to create G27 ΔEPIYA. The C-terminal EPIYA region and motifs were individ-
ually PCR amplified from clinical isolates 7.13, K154, and K341, 73. Strain 7.13, a gerbil adapted isolate that causes 
cancer in the gerbil model of infection73, was utilized as the template for the upstream and downstream EPIYA 
flanking regions to facilitate future creation of H. pylori strains that colonize animals. Korean clinical isolates 
K154 and K3 contain the templates used for the EPIYA-A, -B, and -C or EPIYA-ABD motifs, respectively41. 
The constructs were transformed into G27 ΔEPIYA and transformants were selected for by growth on sucrose; 
the kan-sacB cassette was replaced by double homologous recombination of the various PCR amplified EPIYA 
regions. Subsequently, cagA was amplified from each of the constructed strains and was Sanger sequenced. These 
sequences were then translated and the resulting amino acid sequences were analyzed using Seaview (V.4) to ver-
ify that changes in CagA occurred in the C-terminal EPIYA region. A CagA alignment from each of the isogenic 
strains is provided (Supplementary Figure S1). As controls, a strain in which cagA is deleted (ΔcagA), a strain 
where the cag-pathogenicity island is deleted (ΔPAI), a strain where cagA was disrupted with a chloramphenicol 
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acetyltransferase (cat) cassette (cagA::cat), and a strain that was restored to the original G27 EPIYA genotype 
(ABCC Restorant) were also constructed.
Isogenic Strain CagA Expression, Translocation, and Phosphorylation. To assess CagA expression 
by the isogenic strains, an aliquot of each liquid culture was pelleted and resuspended in lysis buffer (150 mM 
NaCl, 50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 1% SDS, 10% glycerol, and Mini-Complete EDTA-Free Proteinase 
Inhibitor Cocktail). Equal amounts of protein, as determined by a Pierce BCA protein assay, were electrophoresed 
on 4–12% or 8% Bis-Tris gels (Novex by Life Technologies; Grand Island, NY) and transferred to nitrocellu-
lose membranes using the iBlot Gel Transfer Device (Novex by Life Technologies); membranes were blocked 
with phosphate buffered saline (PBS) containing 0.05% tween (PBST) and 5% bovine serum albumin Fraction V 
(BSA). The membranes were probed with a 1:2,000 dilution of rabbit polyclonal IgG anti-CagA (b-300) (Cat #SC-
25766, Lot G2413; Santa Cruz Biotechnology Inc., Dallas, TX) and detected with a 1:8,000 dilution of a bovine 
anti-rabbit IgG-HRP secondary (mouse/human absorbed; Cat #SC2374, lot #I0710; Santa Cruz Biotechnology 
Inc.).
CagA translocation and phosphorylation by the isogenic strains was evaluated by infection of AGS cells 
seeded (3.0–3.5 × 105) 36–48 hrs prior to infection. Briefly, the AGS cells were washed twice with PBS and the 
culture medium was replaced with F-12K (Mediatech Inc.) containing 10% BB, 10% FBS, and 10 µg/mL Vanc, and 
infected at a multiplicity of infection (MOI) of 100 for 8 hrs. Following co-culture, the medium was removed, the 
cells were washed twice with PBS to remove non-adherent H. pylori, and cells were lysed (150 mM NaCl, 50 mM 
Tris-HCl, pH 8.0, 5 mM EDTA, 1% SDS, 10% glycerol, Mini-Complete EDTA-Free Proteinase Inhibitor Cocktail, 
and 0.1 mM Na3VO4). To detect total and phosphorylated CagA, lysates of equal protein concentration were 
Plasmid or Strain Designation Description Reference
Plasmids
pKSF-II pEK::kan-sacB; KanR 71, 72
pDSM530 pGEMT-Easy::7.13ΔEPIYA; AmpR This study
pDSM531 pGEMT-Easy::7.13ΔEPIYA::kan-sacB; AmpR, KanR This study
pDSM532 pGEMT-Easy::ABT; AmpR This study
pDSM533 pGEMT-Easy::ABD, AmpR This study
pDSM547 pGEMT-Easy::ABTD; AmpR This study
pDSM570 pGEMT-Easy::ABTC; AmpR This study
pDSM571 pGEMT-Easy::ABTCC; AmpR This study
pDSM572 pGEMT-Easy::ABTCCC; AmpR This study
pDSM573 pGEMT-Easy::ABTCCCC; AmpR This study
pDSM729 pGEMT-Easy::G27-MA::cagA::cat, AmpR, CmR This study
pDSM730 pGEMT-Easy::G27-MA::ΔPAI::kan; AmpR, KanR 75; This study
pDSM1389 pGEMT-Easy::G27ΔcagA; AmpR This study
pDSM1390 pGEMT-Easy::G27ΔcagA::kan-sacB; AmpR, KanR, SucS This study
pDSM1419 pGEMT-Easy::G27cagA EPIYA; AmpR This study
H. pylori Strains
G27 WT H. pylori 11, 70
DSM48 7.13; gerbil adapted from the clinical strain B128 73
DSM205 G27-MA cagA::cat, CmR 75
DSM206 G27-MA ΔPAI, KanR 75
DSM590 H. pylori Korean clinical isolate K3 41
DSM591 H. pylori Korean clinical isolate K154 41
DSM713 G27ΔEPIYA::kan-sacB; KanR, SucS This study
DSM714 G27 cagA-ABT; This study
DSM715 G27 cagA-ABTC This study
DSM716 G27 cagA-ABTCC This study
DSM717 G27 cagA-ABTCCC This study
DSM718 G27 cagA-ABTCCCC This study
DSM719 G27 cagA-ABTD This study
DSM721 G27 cagA::cat; CmR, results in a truncated CagA product This study
DSM723 G27 ΔPAI; KanR This study
DSM1391 G27 ΔcagA::kan-sacB; KanR, SucS This study
DSM1420 G27 cagA-ABCC Restorant This study
Table 1. Plasmids and strains used in this study. AmpR-ampicillin resistant. CMR-chloramphenicol resistant. 
KanR-kanamycin resistant. SucS-sucrose sensitive.
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electrophoresed on 6% SDS gels and then transferred to nitrocellulose membranes. Membranes were blocked with 
PBST/5% BSA. Phosphorylated CagA was detected using pTyr (P-Tyr-100) mouse mAB (Cat #9411 S; lot #25; 
Cell Signaling Technology, Danvers, MA) and goat anti-mouse IgG-HRP secondary (Cat #SC-2055; Lot #F2413; 
Santa Cruz Biotechnology Inc.). Following detection of phosphorylated CagA, the membranes were stripped (2% 
SDS, 62.5 mM Tris-HCl, pH 6.8, 10 mM DTT) and reprobed for total CagA as described above. All antibodies 
were detected with the Pierce ECL Western Blotting Substrate on an ImageQuant LAS4000 Luminescent Image 
Analyzer (GE Healthcare; Laurel, MD) using ImageQuant LAS4000 Software (GE Healthcare).
Host Cell Elongation. AGS cells were seeded (2.2–2.5 × 105) 18–24 hrs prior to co-culture on 
collagen-coated coverslips and prepared for infection and inoculated as described above. Three, 6, and 9 hrs 
post-infection, the coverslips were washed twice with PBS to remove non-adherent bacteria, fixed for 10 min 
(2.5% paraformaldehyde pH 7.4, 60.75 mM Na2HPO4, pH 9, and 14.3 mM NaH2PO4, pH 4.1), washed with PBS, 
and mounted using Vectashield (Vector Laboratories, Inc., Burlingame, CA). Twenty-four random fields per 
strain were imaged at 63X using differential interference contrast (DIC) microscopy on a Zeiss LSM 5 Pascal 
(Carl Zeiss Microscopy, LLC.; Thornwood, NY) or a Leica AF6000 (Leica Microsystems, Buffalo Grove, IL). 
To determine the relative length/breadth ratio, a total of 200–715 cells/strain were measured from three to six 
independent experiments. For each cell, maximal length was measured along the longest cellular projection and 
maximal width was measured at the widest portion of the cell (adapted from60) using the LSM 5 Image Browser 
software (Carl Zeiss Microscopy, LLC.) or the Leica LAS X software (Leica Microsystems, Inc.). Images were 
exported as TIFF files into Adobe Photoshop CC (Adobe Systems Inc., San Jose, CA) where they were cropped 
and adjusted using the levels function for contrast and brightness. Data and images represent three to six inde-
pendent experiments.
IL-8 Secretion. AGS cells were seeded at 4.2 × 105 for 48 hours. To eliminate activation of host cell sign-
aling pathways due to serum components, the cells were washed twice with PBS and serum starved in F-12K 
(Mediatech, Inc.) for 2 hrs prior to infection. Our preliminary studies also indicated that an FBS concentration 
of 10% masked activation of IL-8 by CagA. Therefore, for infection, the serum free medium was replaced with 
F-12K (Mediatech, Inc.) supplemented with 2% FBS, 10% BB, and 10 µg/mL Vanc, and AGS cells were infected 
at an MOI of 10. A sample of the co-culture supernatant was harvested every 12 hrs for 36 hrs, centrifuged at 
14,000 rpm to pellet any floating cells, and frozen at −20 °C until analysis. The co-culture supernatants were ana-
lyzed using the Human CXCL8/IL-8 Quantikine ELISA kit (R&D Systems; Minneapolis, MN) as per manufactur-
er’s instructions to determine levels of IL-8. ELISA plates were read at an absorbance of 450 nm on a SpectraMax 
M2 plate reader (Molecular Devices; Downingtown, PA). Results represent three to six independent experiments. 
Of note, to control for lot specific differences in absolute values of IL-8 identified with the ELISA kit, we included 
WT G27 in each of our sets of experiments (EPIYA variants in one set and controls in another set) so that we 
could then compare across the experiments.
CagA Translocation, Phosphorylation, and Induction of ERK1/2 Activation. AGS cells were 
seeded (3.0 × 105) for 36–48 hrs. Our preliminary studies indicated that changing the medium on the cells prior 
to infection activated ERK1/2 and that an FBS concentration of 10% masked activation of ERK1/2 by CagA. 
Therefore, to determine baseline ERK1/2 activation, a set of AGS cells was harvested prior to changing the 
media as described below. Next, AGS cells were washed twice with PBS and the medium replaced with F-12K 
(Mediatech, Inc.) supplemented with 2% FBS, 10% BB, and 10 µg/mL Vanc and a set of samples harvested again 
to determine activation of ERK1/2 due to serum components. Following the medium change, the cells were then 
incubated for 3 hrs to allow ERK1/2 activation to return to baseline. Immediately prior to infection, a third set of 
samples was taken for baseline comparisons (time 0) for the time course. AGS cells were then infected at an MOI 
of 100 and samples were harvested temporally. At each time point, the medium was removed, the cells washed 
twice with PBS, and lysed as described above. During harvesting, the lysates were placed on ice followed by son-
ication in an ice-water bath and frozen at −20 °C until analysis. Samples were electrophoresed on 8% Bis-Tris 
gels (Novex by Life Technologies) and transferred to nitrocellulose membranes as described. Membranes were 
blocked with Tris-buffered saline (TBS) containing 0.05% tween (TBST) and 5% BSA, and cut in half horizontally 
between the 49 and 62 kDa ladders. The upper membranes were probed with a 1:500 dilution of pTyr (PY99) 
mouse mAB (Cat #SC-7020 lot #D0115 or C2416; Santa Cruz Biotechnology Inc.) and goat anti-mouse IgG-HRP 
secondary as above. The membranes were then stripped with Re-Blot Plus Strong Solution (Millipore, Billerica, 
MA), prior to detection of total CagA as previously described. The lower membranes were probed for phos-
phorylated ERK1/2 (pERK1/2), which was detected using a 1:1,000 dilution of P-p44/42 MAPK (T202/Y204) 
(D.13.14.4E) XP(R) rabbit mAB (Cat #4370 S; lots #15 and 17; Cell Signaling Technology). The membranes were 
stripped with Re-Blot Plus Strong Solution (Millipore), prior to detection of total ERK1/2 using 1:1,000 dilution 
of p44/42 MAPK (ERK1/2) (137F5) rabbit mAB (Cat #4695 S; lot #21; Cell Signaling Technology). Both P-p44/42 
MAPK and p44/42 MAPK were detected with a 1:20,000 goat anti-rabbit IgG-HRP (Cat #SC-2004; Lot #F2215; 
Santa Cruz Biotechnology, Inc.). GAPDH was utilized as a protein loading control and was detected with goat 
polyclonal anti-GAPDH IgG (L-20; Cat #SC-31915; Lots #D1114 and C1808; Santa Cruz Biotechnology, Inc.) 
and donkey anti-goat IgG-HRP (Cat #SC-2020; Lot #G1615; Santa Cruz Biotechnology, Inc.). Antibodies were 
detected with Hy-Glo Quick Spray (Denville Scientific) as previously described. Due to experimental variation 
across the four independent data sets, the data are displayed as the geometric mean of four biologically independ-
ent experiments and are discussed as trends.
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Data analysis and statistics. GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA) was used for all 
graphs and statistical analysis. To identify differences in host cell elongation, the individual length/breadth ratios 
were grouped by infecting strain or condition, log transformed, and analyzed using an Ordinary one-way analysis 
of variance (ANOVA; GraphPad Software, Inc.). A Tukey’s multiple comparison test with a single pooled variance 
was used to assess multiple comparisons (GraphPad Software, Inc.). The data are graphed as a Tukey’s box and 
whisker plot where any value greater than the 75th percentile plus the 1.5 interquartile distance (IQR) is repre-
sented as an individual point. To determine the percentage of cells that were elongated under each condition, the 
individual length/breadth ratios were grouped as 0 < 4, 4 < 8, and ≥8. These groupings were selected based on 
analysis of the relative length/breadth ratios of the uninfected control cells at the 3 hr time point so that only ~5% 
of the uninfected cells were elongated or had a length/breadth ratio of ≥4. The number of cells in each grouping 
were then divided by the total number of ratios to determine percentages and were graphed as a stacked bar 
graph. Differences in IL-8 ELISA antibody titers were determined on log transformed data by a two-way ANOVA 
with repeated measures for time (GraphPad Software, Inc.). To test the hypothesis that differences exist in IL-8 
secretion between the EPIYA-ABT and EPIYA-C alleles, multiple comparisons were evaluated with a Tukey’s 
multiple comparison test (GraphPad Software, Inc.). To test the hypothesis that IL-8 secretion is increased due 
to the presence of the EPIYA-D allele, multiple comparisons were corrected for using Dunnett’s test (GraphPad 
Software, Inc.). Dunnett’s test was also used to compare IL-8 secretion for all infected cells to uninfected cells and 
IL-8 secretion from cells infected with strains containing an intact EPIYA motif to the cagA::cat infected cells. 
Multiple comparisons among control strains were tested using the Tukey’s multiple comparison test (GraphPad 
Software, Inc.). ELISA data are displayed as the geometric mean +95% confidence interval74. Western blot signals 
were quantified using ImageJ version 1.50 g (National Institutes of Health). Background was removed using the 
subtract background command (rolling ball correction method with a radius set to 25 pixels) and the signal from 
the individual bands was measured using the mean from a region of interest drawn around the band. The box 
size for measuring was the same for the phosphorylated versus total form of the protein. Data for each protein of 
interest were normalized to GAPDH. Due to variation between strains and biological replicates for each protein 
of interest, the normalized value at time zero was designated as “1” and then data were plotted temporally as the 
geometric mean.
Data availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request.
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